default author photo

Bjørg Tilde Svanes Fevang

University of Bergen - Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease

Bergen

Norway

  • University of Bergen - Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease

SCHOLARLY PAPERS

1

DOWNLOADS

51

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 – A Country With a National Tender System for Prescription of Costly Drugs

Number of pages: 29 Posted: 18 Aug 2021
Alen Brkic, Andreas P. Diamantopoulos, Espen Andre Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke, Liz Loli, Camilla Zettel, Erik Rødevand, Gunnstein Bakland, Pawel Mielnik and Glenn Haugeberg
Sorlandet Hospital - Research Department, Martina Hansen Hospital - Department of Rheumatology, Diakonhjemmet Hospital - Division of Rheumatology and Research, University of Bergen - Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Haugesund Hospital for Rheumatic Diseases, Lillehammer Hospital for Rheumatic Diseases, Betanien Hospital - Department of Rheumatology, Trondheim University Hospital - Department of Rheumatology, University Hospital of North Norway - Department of Rheumatology, District General Hospital of Førde - Section for Rheumatology and Sorlandet Hospital - Research Department
Downloads 51 (1,052,702)

Abstract:

Loading...

Rheumatoid Arthritis, Economics, Biological Therapy, Biosimilar Pharmaceuticals